Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosciences sales rise 8% at CSL

This article was originally published in Clinica

Executive Summary

Australian company CSL's biosciences division has reported sales of Aus$12.5 million ($9.6 million) for fiscal 1995 (ended June 30th). The 8% growth in sales of core products - blood grouping reagents, infectious disease diagnostics and products for research laboratories - was able partly to offset the reduction in total revenue brought about by the transfer of the division's international cell culture business to JRH Biosciences which followed the acquisition of JRH by CSL in September 1994.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094441

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel